Thomson Reuters the leading source of intelligent information for the world’s businesses and professionals, providing customers with competitive advantage. Intelligent information is a unique synthesis of human intelligence, industry expertise and innovative technology that provides decision-makers with the knowledge to act, enabling them to make better decisions faster. We deliver this must-have insight to the financial and risk, legal, tax and accounting, intellectual property and science and media markets, powered by the world’s most trusted news organization.
Thomson Reuters provides market-leading data analysis solutions for systems biology. Our tools and manually curated databases help to capture and define the underlying biology behind different types of OMICs data and understand the effects of small molecule drug compounds in human tissues. We provide functional pathway analysis solutions for a wide range of applications in life science research and drug development, from pre-clinical discovery and NCE applications to translational and personalized medicine.